NC Biotech

Locus Biosciences awarded $3.3M from NIH for clinical trial

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has ...

Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bact…

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...
Business Wire

Lactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH’s National Institute of Allergy and Infectious Diseases to Advance Groundbreaking, Mucosal-Targeted Secretory ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a ...
MedPage Today

Proposed Legislation Targets Breaking Up NIAID

Proposed legislation, should it make its way through Congress, would dismantle the National Institute of Allergy and Infectious Diseases (NIAID) as it currently exists, replacing it with three ...
EurekAlert!

NIH officials assess threat of H5N1

Photo of a wild bird. To the right is a colorized transmission electron micrograph of H5N1 virus particles (purple). H5N1 bird flu is widespread in wild birds worldwide, and in 2024 is causing a ...

With ‘much earlier kind of rise in cases,' Waterloo region sees spike in flu cases and hospitalizations

Waterloo region is seeing an "early" spike in flu cases and hospitalizations this flu season and it's potentially because of a new variation of the H3N2 flu strain. David Aoki, director of infectious ...